Mass Spectrometry Facility | Mass Spectrometry Laboratory

Our Facilities

Biognosyshigh-end mass spectrometry facilities in Switzerland and the US provide world-leading capacity for proteomics contract research. From our two facilities, we make a broad spectrum of discovery, targeted, and structural proteomics solutions globally accessible.    

Zurich, Switzerland

Global Headquarters for R&D and Innovation, offering our full portfolio of CRO services

Boston, Massachusetts

Discovery proteomics services for US customers

In our state-of-the-art facilities of in total >1,500 square meters (>15,000 square feet), we can handle large volumes of samples, while maintaining our unprecedented precision and depth. We can deliver many projects in parallel and routinely perform studies with over 1,000 samples for global pharma and biotech customers, academia, or consortia.


We process and store data with utmost protection and operate under comprehensive quality standards. Our Quality Management System (QMS) follows the Organisation for Economic Co-operation and Development (OECD) GLP guidelines and is GCP compliant. This allows us to support our customers in the implementation of proteomics in clinical trials.


We stand for flexibility as well as scalability. We are flexible to support projects of different sizes and sample numbers, depending on the customer’s need. We operate at large scale according to today’s standards, and we are also fully equipped and capable to continuously scale up our throughput to support the rising capacity needs for large-scale proteomics in the future.

Qualified Lab Personnel

Our lab facilities are operated by highly trained personnel with multiple years of proteomics expertise and extensive experience in the handling of various types of projects. Our lab personnel continuously develop and maintain our facilities for optimal performance and uptime.

High-Quality Sample Processing

Our high-end mass spectrometers are set up with automated, tight spaced quality control. They can process samples from any species or biological matrices with high reproducibility.

QMS based on GLP and GCP Guidelines

For pre-clinical studies, our facilities follow the OECD GLP guidelines. For clinical studies, we comply with GCP guidelines based on ICH E6 and the EMA reflection paper for laboratories that perform the analysis or evaluation of clinical trial samples.

Robust, High Capacity Data Center

Our IT infrastructure guarantees timely, error-free, and secure transfer of the mass spectrometric data. The resilient, in-house storage platform is prepared for huge future storage growth.

From our two facilities, we invent and develop proprietary mass spectrometry-based proteomics technologies and offer a broad range of cutting-edge proteomics solutions. We make these widely available to life science researchers and proteomics experts to make the proteome more accessible.

Our Solutions


    Close banner

    New: Hyperplex Biomarker Panels

    Custom Panels for Absolute Protein Quantification

    New: Hyperplex Biomarker Panels

    Custom Panels for Absolute Protein Quantification

    Learn More